1 May 2018 - Yahoo News
Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the Society for Cardiac Robotic Navigation (SCRN) has published a supplement in the European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the ...
usx:stxs
11 Apr 2018 - Yahoo News
LOUIS, April 11, 2018-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that navigation in the pericardial space has been ...
usx:stxs
6 Mar 2018 - Yahoo News
7% year-over-year growth in fourth quarter global procedures and recurring revenue Substantial progress in delineating and initiating strategic innovation plans Increasing quantity and quality of peer-reviewed ...
usx:stxs
6 Mar 2018 - Yahoo News
Enables continued execution of innovation and commercial initiatives Non-dilutive to shareholders Long term lock-up agreement on exercised warrants Represents necessary first step on path to relist on ...
usx:stxs
6 Mar 2018 - Yahoo News
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Stereotaxis Inc. ( OTCQX: STXS ) and OurPet's Co. ( OTCQX: OPCO ), ...
usx:stxs
2 Mar 2018 - Yahoo News
LOUIS, March 02, 2018-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2017 ...
usx:stxs
1 Feb 2018 - Yahoo News
Stereotaxis technology included in recommendations to reduce fluoroscopy exposure and described as allowing“ near zero exposure” to electrophysiologists Clinical data demonstrates significant reduction ...
usx:stxs
8 Jan 2018 - Yahoo News
Revenue of $7.6 million for the fourth quarter and $31.2 million for the full year 2017 Fourth quarter year-over-year revenue growth of 4% and procedure growth of 5% ST. LOUIS, Jan. 08, 2018-- Stereotaxis, ...
usx:stxs
5 Dec 2017 - Yahoo News
LOUIS, Dec. 05, 2017-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has received regulatory clearance from Health ...
usx:stxs